Edition:
United States

Genetic Technologies Ltd (GTG.AX)

GTG.AX on Australia Stock Exchange

0.01AUD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
976,155
52-wk High
$0.02
52-wk Low
$0.01

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 2.12
Market Cap(Mil.): $17.05
Shares Outstanding(Mil.): 2,435.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-Genetic Technologies announces comprehensive review of strategic alternatives

* Genetic Technologies announces comprehensive review of strategic alternatives

Aug 25 2017

Earnings vs. Estimates